|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Tumour overexpressionof inducible nitric oxide synthase(iNOS)increases angiogenesisand may modulate the anti-tumour effects of the vascular disrup-ting agent ZD6126显示文摘 | Cullis ER Kalber TL Ashton SE | 2006 | Microvasc Res2006，71，2： | 1 |
| 2 | ZD1839(Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy显示文摘 | Wakeling AE Guy SP Woodburn JR Ashton SE Curry BJ Barker AJ | 2002 | Cancer Res2002，62，： | 1 |
| 3 | AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer 显示文摘 | Cross DAE Ashton SE Ghiorghiu S | 2014 | Cancer Dis- cov2014，4，9： | 1 |
| 4 | AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer显示文摘 | CROSS DA ASHTON SE GHIORGHIU S et 01 | 2014 | Cancer Discov2014，4，9： | 1 |
| 5 | Flow Cytometric Comparison of Haemocytes From Three Species of Bivalve Mollusks 显示文摘 | Allam B Ashton - Aleox KA Ford SE | 2002 | Fish & Shellfish Immunology2002，13，： | 1 |
| 6 | Azd9291,an irreversible egfr tki,overcomes t790m-mediated resistance to egfr inhibitors in lung cancer显示文摘 | Cross DA Ashton SE Ghiorghiu S | 2014 | Cancer Discov2014，4，： | 1 |
| 7 | AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer显示文摘 | Cross DA Ashton SE Ghiorghiu S | 2014 | Cancer Discov2014，4，9： | 1 |
| 8 | AZD9291, an Irreversible EGFR TKI, overcomes T790M -mediated resisTance to EGFR inhibitors in lung cancer 显示文摘 | CROSS DA ASHTON SE GHIORGHIU S | 2014 | Cancer Discov2014，4，9： | 1 |
| 9 | Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli 显示文摘 | Woodman SE Ashton AW Schubert W | 2003 | Am J Pathol2003，162，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员